Compliance with Therapeutic Goods Association prescribing information: weekly or second weekly cetuximab for the treatment of metastatic colorectal cancer-Reference-Cited by-同舟云学术

Compliance with Therapeutic Goods Association prescribing information: weekly or second weekly cetuximab for the treatment of metastatic colorectal cancer

Published:2022-09-13 Issue: Volume: Page:
ISSN:1444-0903
Container-title:Internal Medicine Journal
language:en
Short-container-title:Internal Medicine Journal

Author:

Loft Matthew¹²^ORCID,Shapiro Jeremy³,Lee Margaret¹²⁴⁵,Wong Rachel¹⁵⁶,Tie Jeanne¹²⁴⁷,Kosmider Suzanne⁴,Wong Vanessa¹^ORCID,Jalali Azim¹⁴^ORCID,Lee Belinda¹⁷,Ananda Sumitra S.¹⁴⁷,Gibbs Peter¹²⁴

Affiliation:

1. Division of Personalised Oncology Walter and Eliza Hall Institute of Medical Research Melbourne Victoria Australia

2. Department of Medical Biology University of Melbourne Melbourne Victoria Australia

3. Department of Medical Oncology Cabrini Hospital Melbourne Victoria Australia

4. Department of Medical Oncology Western Health Melbourne Victoria Australia

5. Department of Medical Oncology Eastern Health Melbourne Victoria Australia

6. Eastern Health Clinical School Monash University Melbourne Victoria Australia

7. Department of Oncology Peter MacCallum Cancer Centre Melbourne Victoria Australia

Publisher

Wiley

Subject

Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imj.15835

Reference21 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Cancer statistics, 2019

3. Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 study

4. Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer

5. Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cetuximab every 2 weeks versus standard weekly dosing administration schedule;Future Oncology;2023-10-18

2. Molecular mechanisms targeting drug-resistance and metastasis in colorectal cancer: Updates and beyond;World Journal of Gastroenterology;2023-03-07